Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Addict Biol ; 21(6): 1113-1126, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-26179931

RESUMEN

Changes in structural plasticity produced by the chronic exposure to drugs of abuse, such as alterations in dendritic spine densities, participate in the development of maladaptive learning processes leading to drug addiction. Understanding the neurobiological mechanisms involved in these aberrant changes is crucial to clarify the neurobiological substrate of addiction. Drug-induced locomotor sensitization has been widely accepted as a useful animal model to study these mechanisms related to drug addiction. We have evaluated the changes in structural plasticity in the mesocorticolimbic system involved in morphine-induced locomotor sensitization. The role of the cannabinoid receptor type 1 (CB1-R) in these neuroplastic alterations has also been studied using CB1-R-deficient (CB1-R KO) mice. Structural plasticity changes promoted by morphine are a highly dynamic phenomenon that evolves during the entire time course of the behavioral sensitization in wild-type (WT) animals. The different phases of the sensitization process were related to specific changes in connectivity between neurons revealed by modifications in dendritic spines in specific areas of the mesocorticolimbic system. Moreover, the lack of morphine-induced locomotor sensitization in CB1-R KO mice was accompanied by abnormal alterations in structural plasticity in the same mesocorticolimbic areas. These specific structural plasticity changes mediated by CB1-R activity seem necessary for the normal progression of morphine-induced locomotor sensitization and could play a critical role in the addictive process.


Asunto(s)
Analgésicos Opioides/farmacología , Morfina/farmacología , Actividad Motora/efectos de los fármacos , Análisis de Varianza , Animales , Dendritas/efectos de los fármacos , Eliminación de Gen , Técnicas de Silenciamiento del Gen , Sistema Límbico/anatomía & histología , Sistema Límbico/efectos de los fármacos , Locomoción/efectos de los fármacos , Ratones Endogámicos C57BL , Ratones Noqueados , Plasticidad Neuronal/efectos de los fármacos , Núcleo Accumbens/anatomía & histología , Núcleo Accumbens/efectos de los fármacos , Receptor Cannabinoide CB1/deficiencia , Receptor Cannabinoide CB1/genética
2.
Nat Med ; 19(5): 603-7, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23542787

RESUMEN

Fragile X syndrome (FXS), the most common monogenic cause of inherited intellectual disability and autism, is caused by the silencing of the FMR1 gene, leading to the loss of fragile X mental retardation protein (FMRP), a synaptically expressed RNA-binding protein regulating translation. The Fmr1 knockout model recapitulates the main traits of the disease. Uncontrolled activity of metabotropic glutamate receptor 5 (mGluR5) and mammalian target of rapamycin (mTOR) signaling seem crucial in the pathology of this disease. The endocannabinoid system (ECS) is a key modulator of synaptic plasticity, cognitive performance, anxiety, nociception and seizure susceptibility, all of which are affected in FXS. The cannabinoid receptors CB1 (CB1R) and CB2 (CB2R) are activated by phospholipid-derived endocannabinoids, and CB1R-driven long-term regulation of synaptic strength, as a consequence of mGluR5 activation, is altered in several brain areas of Fmr1 knockout mice. We found that CB1R blockade in male Fmr1 knockout (Fmr1(-/y)) mice through pharmacological and genetic approaches normalized cognitive impairment, nociceptive desensitization, susceptibility to audiogenic seizures, overactivated mTOR signaling and altered spine morphology, whereas pharmacological blockade of CB2R normalized anxiolytic-like behavior. Some of these traits were also reversed by pharmacological inhibition of mTOR or mGluR5. Thus, blockade of ECS is a potential therapeutic approach to normalize specific alterations in FXS.


Asunto(s)
Endocannabinoides/metabolismo , Síndrome del Cromosoma X Frágil/metabolismo , Animales , Cognición , Femenino , Masculino , Ratones , Ratones Noqueados , Microscopía Fluorescente/métodos , Modelos Biológicos , Piperidinas/uso terapéutico , Pirazoles/uso terapéutico , Proteínas de Unión al ARN/metabolismo , Receptor Cannabinoide CB1/metabolismo , Receptor Cannabinoide CB2/metabolismo , Receptor del Glutamato Metabotropico 5 , Receptores de Glutamato Metabotrópico/metabolismo , Rimonabant
3.
Eur Neuropsychopharmacol ; 23(3): 240-52, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22580057

RESUMEN

Food palatability produces behavioral modifications that resemble those induced by drugs of abuse. Palatability-induced behavioral changes require both, the activation of the endogenous cannabinoid system, and changes in structural plasticity in neurons of the brain reward pathway. The ERK intracellular pathway is activated by CB1 receptors (CB1-R) and plays a crucial role in neuroplasticity. We investigated the activation of the ERK signaling cascade in the mesocorticolimbic system induced by operant training to obtain highly palatable isocaloric food and the involvement of the CB1-R in these responses. Using immunofluorescence techniques, we analyzed changes in ERK intracellular pathway activation in the mesocorticolimbic system of wild-type and CB1 knockout mice (CB1-/-) trained on an operant paradigm to obtain standard, highly caloric or highly palatable isocaloric food. Operant training for highly palatable isocaloric food, but not for standard or highly caloric food, produced a robust activation of the ERK signaling cascade in the same brain areas where this training modified structural plasticity. These changes induced by the operant training were absent in CB1-/-. We can conclude that the activation of the ERK pathway is associated to the neuroplasticity induced by operant training for highly palatable isocaloric food and might be involved in CB1-R mediated alterations in behavior and structural plasticity.


Asunto(s)
Condicionamiento Operante/fisiología , Conducta Alimentaria/fisiología , Sistema de Señalización de MAP Quinasas/fisiología , Plasticidad Neuronal/fisiología , Núcleo Accumbens/metabolismo , Corteza Prefrontal/metabolismo , Animales , Masculino , Ratones , Ratones Noqueados , Fosforilación , Receptor Cannabinoide CB1/genética , Recompensa , Transducción de Señal/fisiología
4.
Eur Neuropsychopharmacol ; 23(2): 146-59, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22612989

RESUMEN

Palatability enhances food intake by hedonic mechanisms that prevail over caloric necessities. Different studies have demonstrated the role of endogenous cannabinoids in the mesocorticolimbic system in controlling food hedonic value and consumption. We hypothesize that the endogenous cannabinoid system could also be involved in the development of food-induced behavioral alterations, such as food-seeking and binge-eating, by a mechanism that requires neuroplastic changes in the brain reward pathway. For this purpose, we evaluated the role of the CB1 cannabinoid receptor (CB1-R) in the behavioral and neuroplastic changes induced by operant training for standard, highly caloric or highly palatable isocaloric food using different genetics, viral and pharmacological approaches. Neuroplasticity was evaluated by measuring changes in dendritic spine density in neurons previously labeled with the dye DiI. Only operant training to obtain highly palatable isocaloric food induced neuroplastic changes in neurons of the nucleus accumbens shell and prefrontal cortex that were associated to changes in food-seeking behavior. These behavioral and neuroplastic modifications induced by highly palatable isocaloric food were dependent on the activity of the CB1-R. Neuroplastic changes induced by highly palatable isocaloric food are similar to those produced by some drugs of abuse and may be crucial in the alteration of food-seeking behavior leading to overweight and obesity.


Asunto(s)
Encéfalo/fisiología , Condicionamiento Operante/fisiología , Vías Nerviosas/fisiología , Plasticidad Neuronal/fisiología , Núcleo Accumbens/fisiología , Corteza Prefrontal/fisiología , Receptor Cannabinoide CB1/fisiología , Recompensa , Adenoviridae , Animales , Encéfalo/efectos de los fármacos , Antagonistas de Receptores de Cannabinoides/farmacología , Condicionamiento Operante/efectos de los fármacos , Espinas Dendríticas/ultraestructura , Alimentos , Vectores Genéticos , Masculino , Ratones , Ratones Noqueados , Plasticidad Neuronal/efectos de los fármacos , Núcleo Accumbens/efectos de los fármacos , Piperidinas/administración & dosificación , Piperidinas/farmacología , Corteza Prefrontal/efectos de los fármacos , Pirazoles/administración & dosificación , Pirazoles/farmacología , Receptor Cannabinoide CB1/antagonistas & inhibidores , Receptor Cannabinoide CB1/genética , Rimonabant
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...